-
08/10/2026, 09:00Oral presentation
-
Andrii Pastushenko (GSI Helmholtzzentrum für Schwerionenforschung)08/10/2026, 09:10Oral presentation
-
Katrin Holzfeind (Technische Universität Wien)08/10/2026, 09:20Oral presentation
-
Giovanni Iadarola (CERN)08/10/2026, 09:30Oral presentation
-
David Ondreka08/10/2026, 11:00Oral presentation
Acceleration of mixed beams with unequal A/Q constitutes an interesting option to enlarge the possible combination of ions delivered simultaneously from a synchrotron, with potential applications in particle therapy, plasma physics, nuclear physics, and materials research. In this scheme, two ion beams are injected sequentially using multi-turn injection and then independently captured and...
Go to contribution page -
Giovanni Iadarola (CERN)08/10/2026, 11:20
-
Elisabeth Renner (Technische Universität Wien)08/10/2026, 13:30Oral presentation
-
Marco Giuseppe Pullia (CNAO)08/10/2026, 13:45Oral presentation
-
Elisabeth Renner (Technische Universität Wien)08/10/2026, 14:05Oral presentation
Over the past three years, significant progress has been achieved in the development of controlled and deliberate mixed-species ion beam delivery at synchrotron facilities. Initially motivated by research on online range monitoring in carbon ion therapy, such beams have been successfully generated, accelerated, and delivered from the synchrotrons at GSI and MedAustron. Establishing this...
Go to contribution page -
Heli Huttunen (CERN)08/10/2026, 14:30Oral presentation
The Helium Light Ion Compact Synchrotron (HeLICS) and its potential superconducting successor, the Carbon Light Ion Compact Synchrotron (C-LICS), are novel synchrotron designs for cancer treatment, developed as part of the Next Ion Medical Machine Study (NIMMS) collaboration. From the perspective of designing new facilities, a preliminary assessment of design considerations to enable the use...
Go to contribution page -
Edgar Cristopher Cortes Garcia (CERN)08/10/2026, 14:50Oral presentation
We present the current status of HEARTS++, a proposed European high-energy heavy-ion irradiation facility to be hosted at CERN. The project targets two critical gaps in the existing landscape: the growing shortage of beam time availability for European academic and industrial users, and the restricted energy range inherent to conventional cyclotron-based facilities.
Go to contribution page -
Dr Martin Schanz (GSI Helmholtzzentrum für Schwerionenforschung GmbH)08/10/2026, 15:05Oral presentation
The GSI Plasma Physics department operates the PRIOR-II proton microscope for FAIR, a powerful, lens-based imaging diagnostic that is capable of visualizing ultra-fast processes in dense matter. However, the technique is also sensitive to small density differences, such as those found in biological matter. This makes it ideal for in situ live imaging and position verification in fast dose...
Go to contribution page -
Luigi Celona (INFN), Michael Galonska (GSI Helmholtzzentrum für Schwerionenforschung GmbH)08/10/2026, 15:50Oral presentation
-
Bernhard Schlitt (GSI Helmholtzzentrum for Heavy Ion Research)08/10/2026, 16:15Oral presentation
The layout and a technical overview of the linac injectors at the ion beam therapy centers HIT and CNAO will be presented. The linacs consist of ECR ion sources, a low-energy beam transport line, a short RFQ, and of an IH-type drift tube linac (DTL). They are designed for acceleration of ions with mass-to-charge ratios up to A/q = 3 to ion energies of about 7 MeV/u. Design criteria,...
Go to contribution page -
Matthias Kausel (MedAustron)08/10/2026, 16:40Oral presentation
Historically, mixed ion beams have been generated - often involuntarily - from a single ion source and simultaneously injected into a synchrotron. As it turns out, this approach is limited by 1) the injector hardware, such as e.g. the ion sources, LINAC cavities, and magnets that might not be able to accommodate the required charge-to-mass ratios (q/m), 2) the ion sources that potentially...
Go to contribution page -
David Ondreka08/10/2026, 17:05Oral presentation
In the past few years, two standard schemes for the generation of mixed C/He beams for online monitoring in particle therapy have emerged: generation of the mixed beam directly in the ion source and generation in the synchrotron by sequential multiturn injection. Together with transverse KO extraction, these schemes serve the purpose of delivering a constant He fraction over the spill very...
Go to contribution page -
08/10/2026, 17:10
-
09/10/2026, 08:30Oral presentation
-
Andrii Pastushenko (GSI Helmholtzzentrum für Schwerionenforschung)09/10/2026, 08:40Oral presentation
Mixed carbon–helium beams are being investigated for ion-beam therapy, where carbon provides the therapeutic dose while a helium component can enable range monitoring. Although the two species have nearly identical charge-to-mass ratios and can be transported simultaneously, small differences in their mass-to-charge ratios can lead to species-dependent dynamics during slow extraction. This...
Go to contribution page -
David Ondreka09/10/2026, 09:05Oral presentation
Acceleration of mixed beams with unequal A/Q, or dual-frequency acceleration, constitutes an interesting option to enlarge the possible combinations of ions delivered simultaneously from a synchrotron, with potential applications in particle therapy, plasma physics, nuclear physics, and materials research. In this scheme, two ion beams are injected sequentially using multi-turn injection and...
Go to contribution page -
Katrin Holzfeind (Technische Universität Wien)09/10/2026, 09:30Oral presentation
-
Elisabeth Renner (Technische Universität Wien), Katrin Holzfeind09/10/2026, 10:40Oral presentation
The commissioning and further development of mixed helium--carbon beam delivery benefit significantely from access to species-resolved beam properties throughout the accelerator complex. As conventional beam diagnostics generally measure the combined beam, dedicated methods are required to distinguish helium and carbon.
This talk discusses diagnostic approaches for different stages of the...
Go to contribution page -
Felix Ulrich-Pur (Marietta-Blau Institut, TU Wien)09/10/2026, 11:05Oral presentation
-
Lennart Volz (GSI Helmholtzzentrum für Schwerionenforschung)09/10/2026, 11:30Oral presentation
Mixed beams hold a great potential for treatment feedback in ion beam therapy. One central question besides the generation of mixed beams resides in what kind of detection system should be used. Ideally, the system should readily keep up with the clinical beam intensities and spot-switching times, be sensitive to even small content of the imaging ion in the beam, and importantly, generate...
Go to contribution page -
Ariadna Cherit Hernández (Department of Medical Physics at the MedAustron site in Wiener Neustadt, Faculty of Medicine, Karl Landsteiner University), Dr Claus Schmitzer (MedAustron Ion Beam Therapy Center, Marie-Curie-Straße 5, 2700 Wiener Neustadt, Austria)Poster
Background/Motivation: SBRT shows promising antiarrhythmic effects in refractory ventricular tachycardia (VT), but photon delivery increases healthy-tissue dose. Carbon ions offer superior conformity and favourable LET, but require accurate range due to motion. Mixed helium–carbon beams may enable in vivo range verification, as helium ions have ~3× the carbon range and exit the patient. We...
Go to contribution page -
Lukas Fuxreiter (TU Wien)Poster
This work presents the first oxygen ion beam tests at MedAustron, which aimed at assessing the feasibility of using the existing 14.5 GHz Electron Cyclotron Resonance Ion Sources (ECRIS) (S2 and S3) installed at MedAustron to generate $^{16}\mathrm{O}^{6+}$ beams. In future studies, these beams shall then be further transported through the LINAC before being stripped to $^{16}\mathrm{O}^{8+}$...
Go to contribution page -
Piera GaleazzoPoster
At MedAustron, a synchrotron-based cancer therapy center located in Austria, Optical Emission Spectroscopy (OES) has been found to be an effective technique for monitoring ion source stability, offering a non-invasive alternative to traditional beam diagnostic devices such as Faraday Cups (FCs). Measurements were performed at the MedAustron injector on one of the three identical Electron...
Go to contribution page -
Harald Handerkas (TU Wien)Poster
For mixed ion beams, two different ion species with the same charge-to-mass ratio are accelerated simultaneously. This contribution refers to mixed He and C beams for medical applications in ion beam therapy. The heavier C ions with lower range are used for the treatment while lighter primary He ions pass the patient. Since both ion species are extracted at the same velocity, the range of C in...
Go to contribution page -
Maximilian Dick (GSI Helmholtz Center for Heavy Ion Research GmbH)Poster
Objective
Mixed helium–carbon beams enable online range monitoring because both ions share the same mass-to-charge ratio and can be accelerated simultaneously, while helium has approximately three times the range in water. Anatomical changes beyond the carbon Bragg peak therefore affect helium, but not carbon. We developed a deep learning approach for spot-wise carbon range prediction...
Go to contribution page
Choose timezone
Your profile timezone: